Effects of Neurofeedback and Transcranial Pulse Stimulation on Attention
1 other identifier
interventional
180
1 country
1
Brief Summary
The present study aims to examine and compare the effectiveness of transcranial pulse stimulation and neurofeedback among adults who are weak in attention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2023
CompletedStudy Start
First participant enrolled
March 17, 2023
CompletedFirst Posted
Study publicly available on registry
April 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedMarch 5, 2025
February 1, 2025
2.2 years
March 17, 2023
February 28, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Change from baseline in Conners' Continuous Performance Test 3rd Edition
The Conners' Continuous Performance Test (CPT) measures inattentiveness, impulsivity, sustained attention, and vigilance. Participants are required to push the spacebar when any letter, except "X", appears. Performances are measured in raw scores and standardized T scores. T scores between 45-54 indicate average performance, higher or lower scores indicate atypical performance.
Baseline, week 4, week 8, week 12, week 16
Change from baseline in gradCPT continuous performance test
The GradCPT is a continuous performance test to measure sustained attention. It has been shown to reliably indicate attentional fluctuation over time. Participants are required to respond to frequently presented city scene and inhibit responses to infrequently presented mountain scene. The sequence of visual stimuli is presented with gradual transitions to minimize involuntary attention capture by abrupt stimulus onset and offset. The main outcome of interest is reaction times variability, with higher variability indicating poorer sustained attention.
Baseline, week 4, week 8, week 12, week 16
Secondary Outcomes (9)
Change from baseline in Stroop task
Baseline, week 4, week 8, week 12, week 16
Change from baseline in General Health Questionnaire
Baseline, week 4, week 8, week 12, week 16
Change from baseline in Goal Orientation Scale
Baseline, week 4, week 8, week 12, week 16
Change from baseline in N-back task
Baseline, week 4, week 8, week 12, week 16
Change from baseline in Color Trails Test
Baseline, week 4, week 8, week 12, week 16
- +4 more secondary outcomes
Study Arms (3)
Neurofeedback
ACTIVE COMPARATORTranscranial pulse stimulation
EXPERIMENTALWaitlist
NO INTERVENTIONInterventions
Participants will be treated with the TPS device NEUROLITH (Storz Medical AG). Treatments will be administered for up to 12 sessions within 4 weeks, each session consisting of 6000 TPS pulses of 0.2 mJ/mm².
Participants will engage in a neurofeedback game designed to increase the ratio of theta/beta frequency bands in electroencephalography measurement. This intervention will be delivered for up to 12 sessions within 4 weeks.
Eligibility Criteria
You may qualify if:
- Aged 20 years and above
- Right-handed
- Normal/corrected hearing and vision
- Having basic literacy skills
- Having sustained attention scores below the threshold
You may not qualify if:
- Having medical history related to brain
- Having mild cognitive impairment
- Showing symptoms of depression and anxiety
- Having intellectual disability based on IQ scores
- Having diagnoses of any psychiatric or cognitive disorders besides attention deficit hyperactivity disorder (ADHD) inattentive and combined types
- Having long-term history of smoking cigarettes
- Engaged in alcohol and/or substance abuse
- Having history of hemophilia or other blood clotting disorders or thrombosis
- Having corticosteroid treatment within the last six weeks before first intervention
- Having contraindications for MRI scanning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HKU InnoCentre of Clinical Neuropsychology
Hong Kong, Hong Kong
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Post-doctoral Fellow
Study Record Dates
First Submitted
March 17, 2023
First Posted
April 28, 2023
Study Start
March 17, 2023
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
March 5, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share